In 2023, the share of US scientific publications in immunology and allergy among the world's top 10% cited was 13.56%. The forecast from 2024 to 2028 indicates a gradual decline from 13.43% to 12.92%, revealing a year-on-year decrease of approximately 1% annually. The compounded annual growth rate (CAGR) over this period shows a negative trend, indicating a slight but consistent drop in the US's relative contribution to top-cited publications in this field.
Future trends to watch include technological advancements in research dissemination, potential shifts in US research funding, and the rise of competing international research hubs which could further impact US dominance in high-impact publications.
